|
|||||
ZanamivirZanamivir Article SummaryZanamivir (inn) (pronounced /znæmvr/) Is A Neuraminidase Inhibitor Used In The Treatment Of And Prophylaxis Of Both Influenzavirus A And Influenzavirus B. Zanamivir Was The First Neuraminidase Inhibitor Commercially Developed. It Is Currently Marketed By Glaxosmithkline Under The Trade Name Relenza. Relenza Is The Only Type Of Zanamivir. contents 1 Development 1.1 Introduction 1.2 Background 1.3 Influenza A 1.4 Influenza B 1.5 Progression Of Relenza 2 Limitations 3 Commercial Diffic ... Read the Full Zanamivir ArticleArticle May Include Instructions, Side Effects, Interactions, Etc. This article is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License) | http://en.wikipedia.org/wiki/Zanamivir Possible Dosages for this and Related Drugs:Note: May Include Dosages for Drugs similar to ZanamivirPowder 5mg Related Drug Page(s): Related Search Results for ZanamivirWebmasters or Publishers: Link To This Drug ListingCopy and Paste the HTML Code Below to Create a Link to this Listing from any Web Page or Email.Graphical Link:
Graphical Link HTML Code: Text Link: Learn About Zanamivir Text Link HTML Code: Related: overdosage reference plan Zanamivir, pharmacy document meds discuss approval Zanamivir, Zanamivir contraindications doctor, guidelines types report Zanamivir, class description questions dose coverage Zanamivir, information review discussions Zanamivir, Zanamivir national trials educate care listing, Zanamivir research generic description symptoms help, Zanamivir addiction druggist, Zanamivir overdosage withdrawal. Return to Top Start a New Discussion About this DrugThis information has been independently compiled and is for educational purposes only. It is not intended to be a substitute for professional medical advice. Please remember that the content within this community is totally compiled by users of this site. Our website displays many pages which do not contain any medical information regarding the drug name stated. These pages are only provided for the purpose of opening community discussions about that drug by our users. For more details please see the Disclaimer. This data is Copyright © 2005-2008 PrescriptionDrug-Info.com and is protected under U.S. and International Copyright laws. All Rights Reserved. Drugs/Zanamivir.asp Last Updated June 27 2005 |
|||||